Riding the Waves: Tools for the Management of Bipolar Disorder

Size: px
Start display at page:

Download "Riding the Waves: Tools for the Management of Bipolar Disorder"

Transcription

1 Riding the Waves: Tools for the Management of Bipolar Disorder Jacintha S. Cauffield, Pharm.D., BCPS, CDE Associate Professor of Pharmacy Practice Palm Beach Atlantic University Lloyd L. Gregory School of Pharmacy West Palm Beach, FL

2 Bipolar Disorder: What are We Treating? Depression Mania Bipolar Disorder Elevated Mood + Increase in energy or goal directed activity

3 Treatment Course Phases Relapse 0 months 2 months 6 months Recurrence Acute Continuation Maintenance CNS Drugs 2011; 25 (10):

4 Mood Stabilizers: Cornerstone of Therapy Effects in both acute and maintenance phases of treatment At least partial amelioration of mania and depression Distinguished from first generation antipsychotics (FGAs; typical antipsychotics)

5 Mood Stabilizers: First Line Agents Lithium Antiseizure Drugs Second Generation Antipsychotics (SGAs) Gold standard Carbamazepine Lamotrigine Valproate Effects depend upon agent Guidelines vary on specific agents

6 Neuroprotective effects Anti-suicide effects Best for euphoric mania High noncompliance rate Side effects in 75% Lithium Discontinuation-induced refractoriness 1/5 of patients

7 Lithium Liabilities: Side Effects Side Effect Central Nervous System (CNS) Toxicity (40%; headache, memory impairment, confusion, difficulty concentrating, impaired motor coordination) Skin effects (acne, psoriasis, rash) Frequent urination (diabetes insipidus) GI (nausea, vomiting, diarrhea) Kidney damage (10-20%?) Thyroid dysfunction (35%; Hypothyroidism) Tremor (hand; 50%; dose-dependent) Methods to Alleviate Minimize dose Temporarily stop medication or switch agents Minimize dose; single bedtime dose; thiazide or loop diuretics (with lithium dose reduction) Take with food, minimize dose, extended release formulation Adequate hydration, minimize dose, once daily dosing, avoid toxicity Levothyroxine Minimize dose, beta blocker

8 Lithium Liabilities: Drug Interactions and Lifestyle Effects Drug High blood pressure medications ACE inhibitors (lisinopril) Angiotensin Receptor Blockers (ARBs) Diuretics ( water pills ) Caffeine Carbamazepine Dehydration FGAs NSAIDs Salt Effect Lithium concentrations Lithium concentrations CNS side effects Lithium concentrations Lithium worsens movement disorders (EPS) Lithium concentrations Increased intake Lithium concentrations

9 Divalproex (Valproic acid; Depakote) Most prescribed mood stabilizer in the US With the exception of SGAs Can be used for: Mania Mixed States Depression More effective than lithium for: Rapid cycling Mixed episodes Substance Use Disorder Can be used with both lithium and carbamazepine

10 Divalproex: Drawbacks Low platelet counts Dose-related >110 mcg/ml in women, >135 mcg/ml in men Hair loss Reversible Dose related? Liver toxicity children <2 years old Monitor liver function Pancreatitis 1-5% incidence Weight Gain

11 Carbamazepine Not first-line; Used for: Lithium nonresponders Mixed states Rapid cyclers

12 Carbamazepine: Monitoring Reaction Monitoring/Action Quick Facts Low blood counts* Monitor CBC Rare Dizziness, gait disturbances Minimum effective dose Serum concentration 4-12 mcg/ml Low sodium Monitor electrolytes More common in elderly Weakness, mental status changes Worse with oxcarbazepine Nausea Give with food Use controlled release formulation Dose-dependent Resolves with time Rash* Test for HLA-B*1502 High risk population: Asian Risk highest in first few months *Black box warnings

13 Lamotrigine Antidepressant Effects Mania Effective in prevention of bipolar depression; used frequently for type II Superior to lithium for depression, inferior for mania Role in acute bipolar depression less clear; small effect size No evidence for role in acute mania or mixed-type episodes

14 Lamotrigine Dosing Alone With Valproate With inducer (carbamazepine, phenytoin, etc.) Weeks mg daily 25 mg every other day 50 mg daily Weeks mg daily 25 mg daily 100 mg daily Week mg daily 50 mg daily 200 mg daily Week mg daily 100 mg daily 400 mg daily Skin rash in lamotrigine o Greater risk given with divalproex and/or aripiprazole If off more than a few days, must restart titration

15 Antipsychotics: Two Classes First Generation Antipsychotics (FGA) Typical Antipsychotics (Selected) Chlorpromazine (Thorazine) Fluphenazine (Prolixin) Haloperidol (Haldol) Perphenazine (Trilafon) Second Generation Antipsychotics (SGA) Atypical Antipsychotics Aripiprazole (Abilify) Asenapine (Saphris) Brexpiprazole (Rexulti) Cariprazine (Vraylar) Clozapine (Clozaril) Iloperidone (Fanapt) Lurasidone (Latuda) Olanzapine (Zyprexa) Paliperidone (Invega) Quetiapine (Seroquel) Risperidone (Risperdal) Ziprasidone (Geodon)

16 Low Potency FGAs High Potency Examples Thorazine (chlorpromazine) Haldol (haloperidol) Prolixin (fluphenazine) Trilafon (perphenazine) Anticholinergia (dry mouth, dry eyes, difficulty peeing, constipation) More Less Weight gain More Less Dizziness when standing up More Less Sedation High Low Hyperprolactinemia Low High Movement Disorders (Extrapyramidal Symptoms; EPS) Less More

17 FGAs: All Have EPS Acute Dystonias Severe Muscle Contractions Pseudo-Parkinsonism Slowing of movements Akathisia Inability to sit still Tardive Dyskinesia Repetitive Involuntary Movements

18 Second Generation Antipsychotics: How are They Different? Less EPS (although some agents do have some) Akathisia Pseudo-Parkinsonism Incidence of tardive dyskinesia is very low Hyperprolactinemia Except Risperdal and Invega Better mood stabilizing abilities Side effect profiles vary more Weight gain Diabetes mellitus

19 Weighing Side Effects Against Benefits (Example: Antipsychotics) Medication Sedation Weight gain/ Diabetes Abilify (Aripiprazole) Low Low High Vraylar (Cariprazine) Low Low High Latuda (Lurasidone) Low Low High Zyprexa (Olanzapine) High High Low Invega (Paliperidone) Low Medium High Seroquel (Quetiapine) High Medium Low Risperdal (Risperidone) Low-Medium Medium High Zyprexa (Ziprasidone) Medium-High Low Low Akathisia / Movement disorders

20 Antipsychotic Use in Bipolar Phases Acute Mania: Aggression/Psychosis* Acute Mania Depression Maintenance Abilify (Aripiprazole) IM (ODT) Yes Yes (Depot Injection) Saphris (Asenapine) Yes (sublingual tablet) Vraylar (Cariprazine) Yes Latuda (Lurasidone) Yes Zyprexa (Olanzapine) IM/PO/ODT Yes Yes (Depot Injection) Invega (Paliperidone) ER only (Depot Injection) Seroquel (Quetiapine) PO Yes Yes Yes Risperdal (Risperidone) PO/ODT Yes Yes (Depot Injection) Geodon (Ziprasidone) IM Yes IM; IM=Intramuscular; ODT=Orally dissolving tablet; ER=extended release; PO= oral Bipolar Disorders 2013:15:1-44

21 Selecting a Mood Stabilizer Lithium Valproate Euphoric mania Previous lithium response Few episodes of illness No psychotic symptoms Mixed state (Dysphoric) Rapid cycling Multiple prior episodes Comorbid substance use disorder

22 Benzodiazepines (Xanax, Klonopin) Restrict to acute mania with: Agitation Anxiety Panic Insomnia Some SGAs are as effective in the acute setting IM injection Dispersible tablets Given high comorbid substance abuse in bipolar disorder, minimize use Taper and d/c as soon as possible

23 ipolar Depression

24 Bipolar Depression: Acute Polypharmacy is common practice Approved Agents Latuda (lurasidone) Seroquel (quetiapine) Zyprexa (olanzapine) + Prozac (fluoxetine) All three have similar efficacy

25 What About Antidepressants? Most commonly used agents for bipolar depression Heavily debated Clinical data to support recommendations is sparse Two main issues: Risk for switching Efficacy

26 Antidepressants: Risk for Switching to Mania Highest High Lowest Tricyclic antidepressants Elavil (amitriptyline) Nortriptyline, desipramine, imipramine SNRIs Cymbalta (duloxetine) Effexor (venlafaxine) SSRIs Prozac (fluoxetine), Paxil (paroxetine) Bupropion

27 Guidance for Using Antidepressants Appropriate: In individual patients With h/o positive response If a patient relapses off of an antidepressant Avoid: Monotherapy in type 1 In mixed episodes With > 2 manic symptoms concomitant with psychomotor agitation or rapid cycling In patients with h/o switching on antidepressants

28 Putting Together a Medication Regimen: Bipolar DO Lamotrigine (careful with valproate) Lurasidone Quetiapine Olanzapine + fluoxetine Lithium Valproate Antipsychotics Depression Mania Bipolar Disorder

29 Why do I need medication?

30 Mental illness can only be treated, not cured Pneumonia + medication = cure The bacteria causing the infection don t belong there Medication kills the bacteria Once we kill them off, they don t come back Diabetes + medication = control The cause of diabetes has to do with how the body works Medication balances the body If we take the medication away, the imbalance returns

31 How does someone feel when they are sick?

32 Treatment Plan Medication Therapy Self Care Healing

33 Medications relieve symptoms so that you can care for yourself.

34 Therapeutic Balance Ideally: no symptoms with no side effects Reality: must balance SYMPTOM CONTROL MEDICATION SIDE EFFECTS

35 Prognosis Best predictor is medication adherence 50% of patients d/c medication due to intolerable side effects 2/3rds receive inadequate treatment due to lack of insight Prognosis worse with: Substance Use Disorder Comorbid psychiatric diagnoses Treat early and fast to maximize chances of relapse prevention doubles rate of medication response

36 What are the challenges of taking medications?

37 They take time to work. Most medications take 1-2 weeks to begin working. Many do not give significant relief for 4-6 weeks, sometimes up to 3 months. If you are experiencing side effects, it s easy to get frustrated and stop taking your medication.

38 The idea of taking medications is scary. It s not natural. I should be able to manage this on my own. So many side effects. What s going to happen to me if I take this for a long time?

39 Weight gain Sleepiness Sexual dysfunction Is it a side effect, or is it my illness? Some side medication side effects are similar to those of untreated mental illness Some side effects go away Nausea Some sedation Headaches Give the medication time to work. Communicate closely and honestly with your provider.

40 Dry mouth Coping with side effects Sip water or sugar free drinks Chew sugar free gum Use sugar free candy (sparingly) Drowsiness Take medication at bedtime if possible Nausea take with food Constipation eat a high fiber diet and drink plenty of water

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Review of Psychotrophic Medications (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Common Psychiatric Disorders *Schizophrenia *Depression *Bipolar Disorder

More information

April 2016 Prepared By: Kimberly D. Griego, PharmD, CGP

April 2016 Prepared By: Kimberly D. Griego, PharmD, CGP April 2016 Prepared By: Kimberly D. Griego, PharmD, CGP Bipolar disorder (BD), also referred to as manic-depression, presents with dramatic swings in a person s mood and energy level, which affects their

More information

Antipsychotics. Something Old, Something New, Something Used to Treat the Blues

Antipsychotics. Something Old, Something New, Something Used to Treat the Blues Antipsychotics Something Old, Something New, Something Used to Treat the Blues Objectives To provide an overview of the key differences between first and second generation agents To an overview the newer

More information

A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer

A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer A Brief Overview of Psychiatric Pharmacotherapy Joel V. Oberstar, M.D. Chief Executive Officer Disclosures Some medications discussed are not approved by the FDA for use in the population discussed/described.

More information

Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children

Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children Judges Reference Table for the Psychotropic Medication Utilization Parameters for Foster Children Stimulants for treatment of ADHD Preschool (Ages 3-5 years) Child (Ages 6-12 years) Adolescent (Ages 13-17

More information

Schedule FDA & literature based indications

Schedule FDA & literature based indications Psychotropic Medication List Recommended dosages are intended to serve only as a guide for children. Recommended doses are literature based. Clinicians should consult package insert of medications for

More information

Psychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA

Psychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA Psychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA Goals of Medications Use least number at lowest dose to get

More information

What Team Members Other Than Prescribers Need To Know About Antipsychotics

What Team Members Other Than Prescribers Need To Know About Antipsychotics What Team Members Other Than Prescribers Need To Know About Antipsychotics The Care Transitions Network National Council for Behavioral Health Montefiore Medical Center Northwell Health New York State

More information

Medications and Children Disorders

Medications and Children Disorders Mental Health Comprehensive Services Providing Family Stability and Developing Life Coping Skills Medications and Children Disorders Psychiatric medications can be an effective part of the treatment for

More information

Mood Disorders.

Mood Disorders. Mood Disorders Shamim Nejad, MD Medical Director, Psycho-Oncology Services Swedish Cancer Institute Swedish Medical Center Seattle, Washington Shamim.Nejad@swedish.org Disclosures Neither I nor my spouse/partner

More information

Slide 1. Slide 2. Slide 3. About this module. About this module. Antipsychotics: The Essentials Module 5 A Primer on Selected Antipsychotics

Slide 1. Slide 2. Slide 3. About this module. About this module. Antipsychotics: The Essentials Module 5 A Primer on Selected Antipsychotics Slide 1 Antipsychotics: The Essentials Module 5 A Primer on Selected Antipsychotics Flavio Guzmán, MD Slide 2 About this module 13 antipsychotics will be studied 3 first generation antipsychotics 10 second

More information

Psychiatric Medication Guide

Psychiatric Medication Guide Psychiatric Medication Guide F O R : N E O N P R I M A R Y H E A L T H C A R E P R O V I D E R S B Y : M I C H E L L E R O M E R O, D O M A Y, 2 0 1 3 Anti-depressants TCA s & MAOI s (Tricyclic Antidepressants

More information

Kelly Godecke, MD Department of Psychiatry University of Utah

Kelly Godecke, MD Department of Psychiatry University of Utah Kelly Godecke, MD Department of Psychiatry University of Utah Epidemiology and Impact -module 2 session 1 overview of mood disorders Diagnostic Criteria of Bipolar Disorders Medications Used in Bipolar

More information

Antipsychotics Prior Authorization Criteria for Louisiana Fee for Service and MCO Medicaid Recipients

Antipsychotics Prior Authorization Criteria for Louisiana Fee for Service and MCO Medicaid Recipients Antipsychotics Prior Authorization Criteria for Louisiana Fee for Service and MCO Medicaid Recipients Preferred Agents (Oral) a Amitriptyline/Perphenazine (Generic) Aripiprazole Tablet (Generic) b Chlorpromazine

More information

New Patient Questionnaire

New Patient Questionnaire 4 Embarcadero Center, Suite 1400, San Francisco, CA 94111 (415) 926-7774 phone; (415) 591-7760 office@sanfranciscopsych.com New Patient Questionnaire Thank you for trusting San Francisco Psychiatry with

More information

Treat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused

Treat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused Psychiatric Drugs Psychiatric Drugs Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally or abused Benzodiazepines

More information

Psychiatric Illness. In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis

Psychiatric Illness. In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis Psychiatric Illness In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis 12,000,000 children infants through 18 y/o nation wide 5,000,000 suffer severely Serious

More information

PSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer

PSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer PSYCHIATRIC DRUGS Mr. D.Raju, M.pharm, Lecturer PSYCHIATRIC DRUGS Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally

More information

REXULTI (brexpiprazole) oral tablet

REXULTI (brexpiprazole) oral tablet REXULTI (brexpiprazole) oral tablet Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy

More information

Depression. University of Illinois at Chicago College of Nursing

Depression. University of Illinois at Chicago College of Nursing Depression University of Illinois at Chicago College of Nursing 1 Learning Objectives Upon completion of this session, participants will be better able to: 1. Recognize depression, its symptoms and behaviors

More information

Ohio Psychotropic Medication Quality Improvement Collaborative. Minds Matter. Toolkit. for You and Your Family. This is the property of

Ohio Psychotropic Medication Quality Improvement Collaborative. Minds Matter. Toolkit. for You and Your Family. This is the property of Minds Matter Ohio Psychotropic Medication Quality Improvement Collaborative Minds Matter Toolkit for You and Your Family This is the property of About Minds Matter Minds Matter is a project to help teens,

More information

Antipsychotics in Bipolar

Antipsychotics in Bipolar Use of Second-Generation Antipsychotics in Bipolar Disorder: A Practical Guide Flavio Guzman, MD Editor Psychopharmacology Institute This practical guide is an update on the use of second-generation antipsychotics

More information

Steps for Initiating Electroconvulsive Therapy Treatment

Steps for Initiating Electroconvulsive Therapy Treatment Steps for Initiating Electroconvulsive Therapy Treatment PSYCHIATRISTS CAN REFER PATIENTS FOR ECT TREATMENT AT EL CAMINO HOSPITAL BY CALLING THE ECT NURSE COORDINATOR AT 650-962-5795. Once the referral

More information

Psychiatry in Primary Care: What is the Role of Pharmacist?

Psychiatry in Primary Care: What is the Role of Pharmacist? Psychiatry in Primary Care: What is the Role of Pharmacist? Benjamin Chavez, PharmD, BCPP, BCACP Clinical Associate Professor Director of Behavioral Health Pharmacy Services January 12, 2019 Disclosure

More information

Treatment Options for Bipolar Disorder Contents

Treatment Options for Bipolar Disorder Contents Keeping Your Balance Treatment Options for Bipolar Disorder Contents Medication Treatment for Bipolar Disorder 2 Page Medication Record 5 Psychosocial Treatments for Bipolar Disorder 6 Module Summary 8

More information

Antipsychotic Medications Age and Step Therapy

Antipsychotic Medications Age and Step Therapy Market DC *- Florida Healthy Kids Antipsychotic Medications Age and Step Therapy Override(s) Approval Duration Prior Authorization 1 year Quantity Limit *Virginia Medicaid See State Specific Mandates *Indiana

More information

Class Update: Oral Antipsychotics

Class Update: Oral Antipsychotics Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119

More information

Pharmacy Medical Necessity Guidelines: Antipsychotic Medications

Pharmacy Medical Necessity Guidelines: Antipsychotic Medications Pharmacy Medical Necessity Guidelines: Antipsychotic Medications Effective: July. 1, 2016 Prior Authorization Required Type of Review Care Management Not Covered Type of Review Clinical Review Pharmacy

More information

How did we get here? 1876 Methylene Blue. Insecticide 1935 Du Pont Anthelmintic. Garrett McCann, RPh

How did we get here? 1876 Methylene Blue. Insecticide 1935 Du Pont Anthelmintic. Garrett McCann, RPh Polypharmacy, Adverse Effects, and the Importance of Tapering Medications for People with Intellectual and Developmental Disabilities Garrett McCann, RPh How did we get here? 1876 Methylene Blue Insecticide

More information

Bipolar Disorder Demystified. Cerrone Cohen, MD FABPN, FABFM Duke Departments of Family Medicine and Psychiatry

Bipolar Disorder Demystified. Cerrone Cohen, MD FABPN, FABFM Duke Departments of Family Medicine and Psychiatry Bipolar Disorder Demystified Cerrone Cohen, MD FABPN, FABFM Duke Departments of Family Medicine and Psychiatry Underdiagnoses of Depression In Primary Care 2005 Study of 650 primary care patients on antidepressants

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Invega Sustenna, Invega Trinza) Reference Number: CP.PHAR.291 Effective Date: 12.01.16 Last Review Date: 08.18 Line of Business: Medicaid See Important Reminder at the end of this policy

More information

Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials

Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials SPEAKER NOTES Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials Summarized by Thomas T. Thomas New psychotropic medications are coming on the

More information

Clinical Policy: Olanzapine Long-Acting Injection (Zyprexa Relprevv) Reference Number: CP.PHAR.292 Effective Date: Last Review Date: 08.

Clinical Policy: Olanzapine Long-Acting Injection (Zyprexa Relprevv) Reference Number: CP.PHAR.292 Effective Date: Last Review Date: 08. Clinical Policy: (Zyprexa Relprevv) Reference Number: CP.PHAR.292 Effective Date: 12.01.16 Last Review Date: 08.18 Line of Business: Medicaid See Important Reminder at the end of this policy for important

More information

A Primer on Psychotropic Medications. Michael Flaum, MD

A Primer on Psychotropic Medications. Michael Flaum, MD The Iowa Mental Health System and Employment for Individuals with Psychiatric Conditions Iowa Vocational Rehabilitation Services Conference Des Moines, IA, September 18, 2006 A Primer on Psychotropic Medications

More information

Guide to Psychiatric Medications for Children and Adolescents

Guide to Psychiatric Medications for Children and Adolescents Guide to Psychiatric Medications for Children and Adolescents by Glenn S. Hirsch, M.D. The following guide includes most of the medications used to treat child and adolescent mental disorders. It lists

More information

HOSPITAL BASED INPATIENT PSYCHIATRIC SERVICES (HBIPS) MEASURE SET

HOSPITAL BASED INPATIENT PSYCHIATRIC SERVICES (HBIPS) MEASURE SET HOSPITAL BASED INPATIENT PSYCHIATRIC SERVICES (HBIPS) MEASURE SET Kathy Wonderly RN, MSEd, CPHQ Consultant Developed: February, 2013 Most recently revised: December 2018 The Psychiatric Measure Set CMS

More information

Psychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Associate Professor of Psychiatry University of Michigan

Psychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Associate Professor of Psychiatry University of Michigan Psychopharmacology in the Emergency Room Michael D. Jibson, M.D., Ph.D. Associate Professor of Psychiatry University of Michigan Pretest 1. Appropriate target symptoms for emergency room medication treatment

More information

Pharmacists in Medication Adherence in Psychiatric Patients

Pharmacists in Medication Adherence in Psychiatric Patients Pharmacists in Medication Adherence in Psychiatric Patients Mamta Parikh, PharmD, BCPS, BCPP Assistant Professor, Clinical and Administrative Sciences Notre Dame of Maryland University School of Pharmacy

More information

Using Drugs to Improve the Behavior of People with Autism: A Skeptical Appraisal. Alan Poling, Ph.D., BCBA-D Western Michigan University

Using Drugs to Improve the Behavior of People with Autism: A Skeptical Appraisal. Alan Poling, Ph.D., BCBA-D Western Michigan University Using Drugs to Improve the Behavior of People with Autism: A Skeptical Appraisal Alan Poling, Ph.D., BCBA-D Western Michigan University In a 2010 study of 60,641 children Mandell et al. found that: 56%

More information

Kelly E. Williams, Pharm.D. PGY2 Psychiatric Pharmacy Resident April 16,2009

Kelly E. Williams, Pharm.D. PGY2 Psychiatric Pharmacy Resident April 16,2009 Kelly E. Williams, Pharm.D. PGY2 Psychiatric Pharmacy Resident April 16,2009 List the antipsychotics most often prescribed Compare and contrast the use and adverse effects experienced in the pediatric

More information

2015 Update on Psychotropics

2015 Update on Psychotropics 2015 Update on Psychotropics Jeffrey T. Apter, M.D. August 2015 Princeton Medical Institute 256 Bunn Drive, Suite 6, Princeton NJ (609) 921-6050 Learning Objectives Upon completion of this session, participants

More information

Michael J. Bailey, M.D. OptumHealth Public Sector

Michael J. Bailey, M.D. OptumHealth Public Sector Michael J. Bailey, M.D. OptumHealth Public Sector LIHP Quality Charter To ensure the quality of care delivered to enrollees in San Diego County Assistance Programs, such as County Medical Services (CMS)

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Abilify Maintena, Aristada, Aristada Initio) Reference Number: CP.PHAR.290 Effective Date: 12.01.16 Last Review Date: 08.18 Line of Business: Medicaid Coding Implications Revision Log

More information

Study Guidelines for Quiz #1

Study Guidelines for Quiz #1 Annex to Section J Page 1 Study Guidelines for Quiz #1 Theory and Principles of Psychopharmacology, Classifications and Neurotransmitters, Anxiolytics/Antianxiety/Minor Tranquilizers, Stimulants, Nursing

More information

Appendix: Psychotropic Medication Reference Tables

Appendix: Psychotropic Medication Reference Tables Appendix: Psychotropic Medication Reference Tables How to Use these Tables These reference tables are designed to provide clinic staff with specific medication related criteria for the Polypharmacy, Cardiometabolic

More information

IOWA MEDICAID DRUG UTILIZATION REVIEW COMMISSION 100 Army Post Road (515)

IOWA MEDICAID DRUG UTILIZATION REVIEW COMMISSION 100 Army Post Road (515) IOWA MEDICAID DRUG UTILIZATION REVIEW COMMISSION 100 Army Post Road (515) 974-3131 -866-626-0216 Brett Faine, Pharm.D. Larry Ambroson, R.Ph. Casey Clor, M.D. Professional Staff: Mark Graber, M.D., FACEP

More information

NorthSTAR. Pharmacy Manual

NorthSTAR. Pharmacy Manual NorthSTAR Pharmacy Manual Revised October, 2008 Table of I. Introduction II. III. IV. Antidepressants New Generation Antipsychotic Medications Mood Stabilizers V. ADHD Medications VI. Anxiolytics and Sedative-Hypnotics

More information

STEP THERAPY CRITERIA

STEP THERAPY CRITERIA DRUG CLASS PRODUCTS) BRAND NAME (BRAND ONLY) (generic) STEP THERAPY CRITERIA ATYPICAL ANTIPSYCHOTICS (BRAND ONLY ABILIFY (AL TABLET & AL SOLUTION ONLY) (aripiprazole) FANAPT (BRAND ONLY) (iloperidone)

More information

Mental Illness. Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling

Mental Illness. Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling Mental Illness Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling Moodiness Changing Bodies Narcissism Self-Esteem Ignorant Naïve Insecure Self-Centered Independent Adolescence Disorders Affecting

More information

Objectives. Antipsychotics 7/25/2016. LeadingAge Florida 53rd Annual Convention & Exposition

Objectives. Antipsychotics 7/25/2016. LeadingAge Florida 53rd Annual Convention & Exposition Reducing the Use of Antipsychotics in Long Term Care Communities Alan W. Obringer RPh, CPh, CGP Executive Director Senior Care Pharmacy Objectives Recognize the clinical evidence for the need to change

More information

PSYCHIATRY INTAKE FORM

PSYCHIATRY INTAKE FORM Please complete all information on this form. PSYCHIATRY INTAKE FORM Name Date Date of Birth Primary Care Physician Current Therapist/Counselor What are the problem(s) for which you are seeking help? 1.

More information

Too Many Meds? How to Prevent Polypharmacy in People with Intellectual/Developmental Disabilities

Too Many Meds? How to Prevent Polypharmacy in People with Intellectual/Developmental Disabilities Too Many Meds? How to Prevent Polypharmacy in People with Intellectual/Developmental Disabilities One definition of polypharmacy is using more medications than is medically necessary. However, it can be

More information

Antidepressants. Dr Malek Zihlif

Antidepressants. Dr Malek Zihlif Antidepressants The optimal use of antidepressant required a clear understanding of their mechanism of action, pharmacokinetics, potential drug interaction and the deferential diagnosis of psychiatric

More information

Introduction to Drug Treatment

Introduction to Drug Treatment Introduction to Drug Treatment LPT Gondar Mental Health Group www.le.ac.uk Introduction to Psychiatric Drugs Drugs and Neurotransmitters 5 Classes of Psychotropic medications Mechanism of action Clinical

More information

TRANSCRANIAL MAGNETIC STIMULATION & BRAIN MUSIC THERAPY

TRANSCRANIAL MAGNETIC STIMULATION & BRAIN MUSIC THERAPY TMS - DEPRESSION HISTORY Date: Patient Name: DOB: How did you hear about TMS? What do you know about TMS? Referring Physician? Name of Practice: Name of Inpatient Treatment for Depression: Name of Inpatient

More information

COMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications*

COMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications* COMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications* Bupropion (Wellbutrin) Start: IR-100 mg bid X 4d then to 100 mg tid; SR-150

More information

Anti- Depressants, Mood Stabilizers: What Works Best For Bipolar Disorder? Date: March 30, 2007 Source: NIH/National Institute of.

Anti- Depressants, Mood Stabilizers: What Works Best For Bipolar Disorder? Date: March 30, 2007 Source: NIH/National Institute of. 30-3-2007 Anti- Depressants, Mood Stabilizers: What Works Best For Bipolar Disorder? Date: March 30, 2007 Source: NIH/National Institute of. 30-3-2018 C. Psychiatric drugs: controlled trial demonstrated

More information

Class: Treatment with Medication:

Class: Treatment with Medication: Class: As we have not finished all the material covering disorders, I wanted to give you and overview of some disorders we have not had a chance to discuss. I feel you are well prepared in different types

More information

Medically Accepted Indications for Pediatric Use of Psychotropic Medications by

Medically Accepted Indications for Pediatric Use of Psychotropic Medications by Key: White Background: Medically Accepted Indication Yellow Backgroun: Medically Accepted Indication Status Not Ascertained Orange Background: Pediatric Indication cited, but not supported Red Background:

More information

PDF created with pdffactory Pro trial version

PDF created with pdffactory Pro trial version با ی د ر ا ر وه روا ز ش ی دا ه ع وم ش ی ا ان Treatment Challenges in BD Major depressive episode Mixed states= 20% Rapid cycling= 18% (annually), 31.5% (lifetime) Psychiatric Comorbidity (substance abuse,

More information

Objectives. Mental Health Info MEDICATION USE IN ASSISTED LIVING FACILITIES FOR MENTAL HEALTH ISSUES 11/12/2018

Objectives. Mental Health Info MEDICATION USE IN ASSISTED LIVING FACILITIES FOR MENTAL HEALTH ISSUES 11/12/2018 MEDICATION USE IN ASSISTED LIVING FACILITIES FOR MENTAL HEALTH ISSUES Holly Altenberger, PharmD, RPh Director of Pharmacy O Connell Pharmacy holly@oconnellpharmacy.com Objectives At the conclusion of the

More information

Pharmacy Benefit Management (PBM) Program FORMULARY/PRODUCT RESTRICTIONS

Pharmacy Benefit Management (PBM) Program FORMULARY/PRODUCT RESTRICTIONS Workforce Safety & Insurance Revised Document Date: 07/21/2015 1600 E Century Ave Ste 1 PO Box 5585 Bismarck, ND 58506-5585 701.328.3800 1.800.777.5033 www.workforcesafety.com Pharmacy Benefit Management

More information

Criteria for Child Psychiatrist on the Use of Selected Psychotropic Medications in Children & Adolescents

Criteria for Child Psychiatrist on the Use of Selected Psychotropic Medications in Children & Adolescents Criteria for Child Psychiatrist on the Use of Selected Psychotropic Medications in Children & Adolescents DRUG NAME INDICATIONS / ACCEPTABLE USES PRIOR STIMULANT/ADHD DRUGS Daytrana (methylphenidate) ADHD

More information

Treat Schizophrenia Schizoaffective disorder Bipolar disorder Psychotic depression Off-label uses Insomnia Tics Delirium Stuttering

Treat Schizophrenia Schizoaffective disorder Bipolar disorder Psychotic depression Off-label uses Insomnia Tics Delirium Stuttering Robert M. Millay RN MSN Ed Professor, Napa Valley College Psychiatric Technician Programs Copyright 2015, 2011, 2007, 2003, 1999, 1995, 1991 by Mosby, an imprint of Elsevier Inc. Treat Schizophrenia Schizoaffective

More information

Psychiatric Medications. Positive and negative effects in the classroom

Psychiatric Medications. Positive and negative effects in the classroom Psychiatric Medications Positive and negative effects in the classroom Teaching the Medicated Child Beverly Bryant, M.D. Hattiesburg Clinic 9/17/14 Introduction According to the National Survey of Children

More information

First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness

First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness 1 First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness This continuing education monograph examines the results of a comparative effectiveness review to compare

More information

Objectives. Epidemiology. Diagnosis 3/27/2013. Identify positive and negative symptoms used for diagnosis of schizophrenia

Objectives. Epidemiology. Diagnosis 3/27/2013. Identify positive and negative symptoms used for diagnosis of schizophrenia Objectives Identify positive and negative symptoms used for diagnosis of schizophrenia Mohamed Sallout, Pharm D. Pharmacist Resident St. Luke s Magic Valley Regional Medical Center List medications used

More information

Psychopharmacologic Updates. Nimisha Gokaldas, MD Medical Director Multnomah County, Mental Health and Addiction Services Division

Psychopharmacologic Updates. Nimisha Gokaldas, MD Medical Director Multnomah County, Mental Health and Addiction Services Division Psychopharmacologic Updates Nimisha Gokaldas, MD Medical Director Multnomah County, Mental Health and Addiction Services Division This author has NO affiliations with or involvement in any organization

More information

ASENAPINE. THERAPEUTICS Brands SAPHRIS see index for additional brand names

ASENAPINE. THERAPEUTICS Brands SAPHRIS see index for additional brand names ASENAPINE THERAPEUTICS Brands SAPHRIS see index for additional brand names Generic? No Class Neuroscience-based Nomenclature: dopamine, serotonin, norepinephrine receptor antagonist (DSN-RAn) Atypical

More information

Pharmaceutical Interventions. Collaborative Model of Mental Health Care for Older Iowans Des Moines May 18, 2007

Pharmaceutical Interventions. Collaborative Model of Mental Health Care for Older Iowans Des Moines May 18, 2007 Pharmaceutical Interventions Collaborative Model of Mental Health Care for Older Iowans Des Moines May 18, 2007 Outline Overview Overview of initial workup and decisions in elderly depressed individual

More information

Rexulti (brexpiprazole)

Rexulti (brexpiprazole) Market DC Rexulti (brexpiprazole) Override(s) Approval Duration Prior Authorization 1 year Quantity Limit *Indiana see State Specific Mandates below *Maryland see State Specific Mandates below *Virginia

More information

IMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members

IMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members IMPORTANT NOTICE Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members These changes apply only to members covered under the DC Healthcare Alliance program Alliance

More information

Psychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Professor of Psychiatry University of Michigan

Psychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Professor of Psychiatry University of Michigan Psychopharmacology in the Emergency Room Michael D. Jibson, M.D., Ph.D. Professor of Psychiatry University of Michigan Pretest 1. Which of the following conditions is LEAST likely to benefit from emergency

More information

Medication Audit Checklist- Antipsychotics - Atypical

Medication Audit Checklist- Antipsychotics - Atypical Medication Audit checklist Page 1 of 7 10-2018 Audit number: Client number: Ordering Provider: INDICATIONS 1) Disorders with psychotic symptoms (schizophrenia, schizoaffective disorder, manic disorders,

More information

ARIPIPRAZOLE. THERAPEUTICS Brands Abilify Abilify Maintena Aristada see index for additional brand names. Generic? Yes

ARIPIPRAZOLE. THERAPEUTICS Brands Abilify Abilify Maintena Aristada see index for additional brand names. Generic? Yes ARIPIPRAZOLE THERAPEUTICS Brands Abilify Abilify Maintena Aristada see index for additional brand names Generic? Yes Class Neuroscience-based Nomenclature: dopamine, serotonin receptor partial agonist

More information

med ed Copyright All rights reserved. No part of this publication can be reproduced without prior written consent of the authors.

med ed Copyright All rights reserved. No part of this publication can be reproduced without prior written consent of the authors. med ed Dr. Andrea Murphy, Assistant Professor, School of Nursing, Dalhousie University; Research Associate, Sun Life Financial Chair in Adolescent Mental Health Dr. David Gardner, Associate Professor,

More information

4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies

4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies Child & Adolescent Behavioral Medicine & Medication Therapies Brian J Cowles, PharmD Associate Professor of Pharmacy Practice Albany College of Pharmacy & Health Sciences; Vermont Campus Behavioral Medicine

More information

MO Medicaid Foster Care Drugs FY10-FY14

MO Medicaid Foster Care Drugs FY10-FY14 MO Medicaid Foster Care Drugs FY10-FY14 Medicaid (MO HealthNet) Cost of Drugs given to Missouri Foster Care Children by combinations of Age, Gender, Drug Class and Fiscal Year [Raw Data Provided by Missouri

More information

Antipsychotics and stroke risk

Antipsychotics and stroke risk Integrating Sentinel into Routine Regulatory Drug Review: A Snapshot of the First Year Antipsychotics and stroke risk Lockwood G. Taylor, PhD, MPH Division of Epidemiology II Office of Pharmacovigilance

More information

Symbyax (Zyprexa [olanzapine] and Prozac [fluoxetine] combination)

Symbyax (Zyprexa [olanzapine] and Prozac [fluoxetine] combination) Symbyax (Zyprexa [olanzapine] and Prozac [fluoxetine] combination) Generic name: Olanzapine and fluoxetine combination Available strengths: 6 mg/25 mg, 6 mg/50 mg, 12 mg/25 mg, 12 mg/50 mg (Zyprexa/Prozac)

More information

BLONANSERIN. THERAPEUTICS Brands Lonasen see index for additional brand names

BLONANSERIN. THERAPEUTICS Brands Lonasen see index for additional brand names BLONANSERIN THERAPEUTICS Brands Lonasen see index for additional brand names Generic? No Class Atypical antipsychotic (serotonin dopamine antagonist; second-generation antipsychotic; also a potential mood

More information

Current Non-Preferred Agents

Current Non-Preferred Agents Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35, Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119

More information

Pharmacy Medical Necessity Guidelines: Antipsychotic Medications

Pharmacy Medical Necessity Guidelines: Antipsychotic Medications Pharmacy Medical Necessity Guidelines: Effective: October 1, 2016 Prior Authorization Required Type of Review Care Management Not Covered Type of Review Clinical Review Pharmacy (RX) or Medical (MED) Benefit

More information

Disclosure. Objectives: Technician. Objectives: Pharmacist. Diagnostic and Statistical Manual (DSM-V) The Face of Mental Illness 7/25/2015

Disclosure. Objectives: Technician. Objectives: Pharmacist. Diagnostic and Statistical Manual (DSM-V) The Face of Mental Illness 7/25/2015 49th Annual Meeting Psychiatry for the Non-Psychiatry Specialist Jacintha Cauffield, PharmD, BCPS, CDE Associate Professor of Pharmacy Practice Lloyd L. Gregory School of Pharmacy Palm Beach Atlantic University

More information

Ohio Psychotropic Medication Quality Improvement Collaborative. Minds Matter. Toolkit. for Youth and Caregivers. This is the property of

Ohio Psychotropic Medication Quality Improvement Collaborative. Minds Matter. Toolkit. for Youth and Caregivers. This is the property of Minds Matter Ohio Psychotropic Medication Quality Improvement Collaborative Minds Matter Toolkit for Youth and Caregivers This is the property of About Minds Matter Minds Matter is a statewide project

More information

Medications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation

Medications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation Medications for Anxiety & Behavior in Williams Syndrome Christopher J. McDougle, M.D. Director, Lurie Center for Autism Professor of Psychiatry and Pediatrics Massachusetts General Hospital and MassGeneral

More information

Review Session 3. Case. Annemarie Mikowski DO Assistant Clinical Instructor Chief Resident Psychiatry

Review Session 3. Case. Annemarie Mikowski DO Assistant Clinical Instructor Chief Resident Psychiatry Review Session 3 Annemarie Mikowski DO Assistant Clinical Instructor Chief Resident Psychiatry Case A 26 y/o F describes difficulty sleeping. She has been feeling steadily overwhelmed and anxious at her

More information

Richard Heidenfelder M.D. Child, Adolescent and Adult Psychiatry 447 9th Ave San Diego, CA

Richard Heidenfelder M.D. Child, Adolescent and Adult Psychiatry 447 9th Ave San Diego, CA *We are not accepting any New Patients who are currently taking any controlled pain medications *We are *Note: not completion accepting of the any following New Patients paperwork who and Initial are Screening

More information

Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist. HMS Training Webinar January 27, 2017

Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist. HMS Training Webinar January 27, 2017 Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist HMS Training Webinar January 27, 2017 1 Describe nationwide prevalence and types of elderly dementia + define BPSD Define psychotropic

More information

BIPOLAR DISORDERS DIAGNOSTIC AND TREATMENT ISSUES RICHARD RIES MD

BIPOLAR DISORDERS DIAGNOSTIC AND TREATMENT ISSUES RICHARD RIES MD Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences BIPOLAR DISORDERS DIAGNOSTIC AND TREATMENT ISSUES RICHARD RIES MD PROFESSOR DEPARTMENT OF PSYCHIATRY UNIVERSITY

More information

Presentation is Being Recorded

Presentation is Being Recorded Integrated Care for Depression & Anxiety Psychotropic Medication Management for Primary Care Providers Los Angeles County Department of Mental Health September 20, 2011 Presentation is Being Recorded Please

More information

Comparison of Atypical Antipsychotics

Comparison of Atypical Antipsychotics PL Detail-Document #281006 This PL Detail-Document gives subscribers additional insight related to the Recommendations published in PHARMACIST S LETTER / PRESCRIBER S LETTER October 2012 Comparison of

More information

CONTRAINDICATIONS TABLE

CONTRAINDICATIONS TABLE CONTRAINDICATIONS TABLE Generic Name Brand Name Contraindications Amphetamine Salts Adderall, Adderall XR Hypersensitivity to amphetamine, dextroamphetamine, or other sympathomimetic amines Advanced arteriosclerosis

More information

9/20/2011. Integrated Care for Depression & Anxiety: Psychotropic Medication Management for PCPs. Presentation is Being Recorded

9/20/2011. Integrated Care for Depression & Anxiety: Psychotropic Medication Management for PCPs. Presentation is Being Recorded Integrated Care for Depression & Anxiety Psychotropic Medication Management for Primary Care Providers Los Angeles County Department of Mental Health September 20, 2011 Presentation is Being Recorded Please

More information

Objectives. DSM-V Changes: Elimination of Multiaxial Diagnostic System

Objectives. DSM-V Changes: Elimination of Multiaxial Diagnostic System Conflicts of Interest I have no conflicts to disclose. 2014 Updates to the Updates in Pharmacotherapy Webinar Psychiatry Updates for Pharmacotherapy Specialists Jacintha S. Cauffield, Pharm.D., BCPS Associate

More information

Step Therapy Group. Atypical Antipsychotic Agents

Step Therapy Group. Atypical Antipsychotic Agents Atypical Antipsychotic Agents Any beneficiary newly enrolled into Community Care, Inc. currently receiving aripiprazole, aripiprazole ODT, risperidone, risperidone ODT, olanzapine, olanzapine ODT, quetiapine,

More information

ILOPERIDONE. THERAPEUTICS Brands FANAPT see index for additional brand names. Generic? No

ILOPERIDONE. THERAPEUTICS Brands FANAPT see index for additional brand names. Generic? No ILOPERIDONE THERAPEUTICS Brands FANAPT see index for additional brand names Generic? No Class Neuroscience-based Nomenclature: dopamine and serotonin receptor antagonist (DS-RAn) Atypical antipsychotic

More information

LURASIDONE. THERAPEUTICS Brands LATUDA see index for additional brand names

LURASIDONE. THERAPEUTICS Brands LATUDA see index for additional brand names LURASIDONE THERAPEUTICS Brands LATUDA see index for additional brand names Generic? No Class Neuroscience-based Nomenclature: dopamine, serotonin receptor antagonist (DS-RAn) Atypical antipsychotic (serotonin-dopamine

More information